$CBPO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in China Biologic Products Holdings, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in China Biologic Products Holdings, Inc.. Get notifications about new insider transactions in China Biologic Products Holdings, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20 2013 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Grant | A | 0.00 | 80,000 | 0 | 92,000 | 12 K to 92 K (+666.67 %) |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Li Bing | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Grant | A | 0.00 | 6,000 | 0 | 11,000 | 5 K to 11 K (+120.00 %) |
| May 15 2013 | CBPO | China Biologic Pro ... | WP X Biologics LLC | Director | Buy | P | 20.00 | 3,112,920 | 62,258,400 | 10,989,200 | 7.9 M to 11 M (+39.52 %) |
| May 15 2013 | CBPO | China Biologic Pro ... | Li Lin Ling | Sell | S | 20.00 | 3,112,920 | 62,258,400 | 1,529,704 | 4.6 M to 1.5 M (-67.05 %) | |
| Nov 30 2012 | CBPO | China Biologic Pro ... | Zhao Chao Ming | President | Sell | S | 15.00 | 200,000 | 3,000,000 | 621,787 | 821.8 K to 621.8 K (-24.34 %) |
| Sep 17 2012 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Buy | P | 8.93 | 5,000 | 44,641 | 12,000 | 7 K to 12 K (+71.43 %) |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Option Exercise | A | 9.85 | 5,000 | 49,250 | 25,000 | |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Shao Sean | Director | Grant | A | 0.00 | 17,500 | 0 | 17,500 | 0 to 17.5 K |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Lu Yungang | Director | Option Exercise | A | 9.85 | 10,000 | 98,500 | 30,000 | |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Lu Yungang | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Option Exercise | A | 9.85 | 5,000 | 49,250 | 25,000 | |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Option Exercise | A | 9.85 | 50,000 | 492,500 | 50,000 | |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Option Exercise | A | 9.85 | 300,000 | 2,955,000 | 620,000 | |
| Sep 05 2012 | CBPO | China Biologic Pro ... | Li Bing | Director | Option Exercise | A | 9.85 | 10,000 | 98,500 | 30,000 | |
| Jul 31 2012 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Option Exercise | A | 10.57 | 20,000 | 211,400 | 20,000 | |
| Jun 05 2012 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 12.50 | 1,608,363 | 20,104,538 | 7,876,280 | 6.3 M to 7.9 M (+25.66 %) |
| May 15 2012 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Buy | P | 9.50 | 2,710 | 25,745 | 7,000 | 4.3 K to 7 K (+63.17 %) |
| May 14 2012 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Option Exercise | A | 9.23 | 300,000 | 2,769,000 | 320,000 | |
| May 14 2012 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Buy | P | 9.50 | 4,290 | 40,755 | 4,290 | 0 to 4.3 K |
| Dec 19 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.44 | 253,236 | 2,895,931 | 6,267,917 | 6 M to 6.3 M (+4.21 %) |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.65 | 31,904 | 371,570 | 5,761,220 | 5.7 M to 5.8 M (+0.56 %) |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.28 | 47,461 | 535,241 | 5,729,316 | 5.7 M to 5.7 M (+0.84 %) |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | CFO | Option Exercise | M | 4.00 | 5,000 | 20,000 | 110,000 | |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | CFO | Option Exercise | M | 4.00 | 20,000 | 80,000 | 115,000 | |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | CFO | Option Exercise | M | 4.00 | 25,000 | 100,000 | 135,000 | |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | CFO | Sell | S | 11.60 | 5,000 | 58,000 | 0 | 5 K to 0 (-100.00 %) |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | CFO | Buy | M | 4.00 | 5,000 | 20,000 | 5,000 | 0 to 5 K |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | CFO | Sell | S | 11.69 | 20,000 | 233,850 | 0 | 20 K to 0 (-100.00 %) |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | CFO | Buy | M | 4.00 | 20,000 | 80,000 | 20,000 | 0 to 20 K |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | CFO | Sell | S | 11.34 | 25,000 | 283,500 | 0 | 25 K to 0 (-100.00 %) |
| Dec 14 2011 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | CFO | Buy | M | 4.00 | 25,000 | 100,000 | 25,000 | 0 to 25 K |
| Dec 16 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.33 | 216,146 | 2,447,940 | 6,014,681 | 5.8 M to 6 M (+3.73 %) |
| Dec 16 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.59 | 37,315 | 432,488 | 5,798,535 | 5.8 M to 5.8 M (+0.65 %) |
| Dec 12 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.53 | 49,600 | 572,012 | 5,681,855 | 5.6 M to 5.7 M (+0.88 %) |
| Dec 09 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 11.01 | 32,723 | 360,130 | 5,632,255 | 5.6 M to 5.6 M (+0.58 %) |
| Dec 09 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 10.51 | 25,066 | 263,361 | 5,599,532 | 5.6 M to 5.6 M (+0.45 %) |
| Dec 07 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 10.10 | 94,210 | 951,860 | 5,574,466 | 5.5 M to 5.6 M (+1.72 %) |
| Dec 07 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 9.62 | 6,630 | 63,781 | 5,480,256 | 5.5 M to 5.5 M (+0.12 %) |
| Dec 01 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 7.78 | 15,267 | 118,808 | 5,465,745 | 5.5 M to 5.5 M (+0.28 %) |
| Dec 01 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 7.33 | 28,421 | 208,414 | 5,450,478 | 5.4 M to 5.5 M (+0.52 %) |
| Dec 05 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 9.43 | 1,748 | 16,492 | 5,473,626 | 5.5 M to 5.5 M (+0.03 %) |
| Dec 05 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 8.58 | 6,133 | 52,639 | 5,471,878 | 5.5 M to 5.5 M (+0.11 %) |
| May 31 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 16.14 | 109,721 | 1,770,875 | 5,422,057 | 5.3 M to 5.4 M (+2.07 %) |
| May 31 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 16.26 | 97,440 | 1,584,111 | 5,312,336 | 5.2 M to 5.3 M (+1.87 %) |
| May 26 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 15.41 | 35,362 | 544,776 | 5,214,896 | 5.2 M to 5.2 M (+0.68 %) |
| May 26 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 15.15 | 257,114 | 3,896,408 | 5,179,534 | 4.9 M to 5.2 M (+5.22 %) |
| May 25 2011 | CBPO | China Biologic Pro ... | Shao Sean | Director | Option Exercise | M | 4.00 | 10,000 | 40,000 | 70,000 | |
| May 25 2011 | CBPO | China Biologic Pro ... | Shao Sean | Director | Sell | S | 15.25 | 5,600 | 85,400 | 0 | 5.6 K to 0 (-100.00 %) |
| May 25 2011 | CBPO | China Biologic Pro ... | Shao Sean | Director | Sell | S | 14.95 | 400 | 5,980 | 5,600 | 6 K to 5.6 K (-6.67 %) |
| May 25 2011 | CBPO | China Biologic Pro ... | Shao Sean | Director | Sell | S | 14.71 | 4,000 | 58,840 | 6,000 | 10 K to 6 K (-40.00 %) |
| May 25 2011 | CBPO | China Biologic Pro ... | Shao Sean | Director | Option Exercise | M | 4.00 | 10,000 | 40,000 | 80,000 | |
| May 25 2011 | CBPO | China Biologic Pro ... | Shao Sean | Director | Sell | S | 14.07 | 24 | 338 | 0 | 24 to 0 (-100.00 %) |
| May 25 2011 | CBPO | China Biologic Pro ... | Shao Sean | Director | Sell | S | 14.08 | 5,971 | 84,072 | 24 | 6 K to 24 (-99.60 %) |
| May 25 2011 | CBPO | China Biologic Pro ... | Shao Sean | Director | Sell | S | 14.05 | 4,005 | 56,270 | 5,995 | 10 K to 6 K (-40.05 %) |
| May 24 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 14.82 | 14,869 | 220,290 | 4,922,420 | 4.9 M to 4.9 M (+0.30 %) |
| May 24 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | Director | Buy | P | 14.91 | 20,030 | 298,629 | 4,907,551 | 4.9 M to 4.9 M (+0.41 %) |
| May 20 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 14.66 | 28,751 | 421,380 | 4,887,521 | 4.9 M to 4.9 M (+0.59 %) |
| May 20 2011 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 14.21 | 38,770 | 550,798 | 4,858,770 | 4.8 M to 4.9 M (+0.80 %) |
| Jan 28 2011 | CBPO | China Biologic Pro ... | Shao Sean | Director | Option Exercise | A | 16.39 | 30,000 | 491,700 | 90,000 | |
| Jan 28 2011 | CBPO | China Biologic Pro ... | Lin Tong Jun | Director | Option Exercise | A | 16.39 | 30,000 | 491,700 | 90,000 | |
| Jan 28 2011 | CBPO | China Biologic Pro ... | Cui Xiangmin | Director | Option Exercise | A | 16.39 | 30,000 | 491,700 | 90,000 | |
| Dec 17 2010 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 17.35 | 8,265 | 143,398 | 4,820,000 | 4.8 M to 4.8 M (+0.17 %) |
| Dec 17 2010 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 16.64 | 91,735 | 1,526,012 | 4,811,735 | 4.7 M to 4.8 M (+1.94 %) |
| Dec 17 2010 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 16.54 | 9,000 | 148,829 | 4,720,000 | 4.7 M to 4.7 M (+0.19 %) |
| Dec 17 2010 | CBPO | China Biologic Pro ... | Warburg Pincus Private Equity ... | 10% Owner | Buy | P | 15.83 | 41,000 | 648,895 | 4,711,000 | 4.7 M to 4.7 M (+0.88 %) |
| Dec 14 2010 | CBPO | China Biologic Pro ... | Li Lin Ling | Director | Sell | S | 13.00 | 1,500,000 | 19,500,000 | 4,592,624 | 6.1 M to 4.6 M (-24.62 %) |
| Dec 14 2010 | CBPO | China Biologic Pro ... | CHAN LING SIU | Director | Sell | S | 13.00 | 1,500,000 | 19,500,000 | 5,362,624 | 6.9 M to 5.4 M (-21.86 %) |
| Sep 09 2010 | CBPO | China Biologic Pro ... | Zhao Chao Ming | Chief Executive Off ... | Sell | S | 13.00 | 200,000 | 2,600,000 | 821,787 | 1 M to 821.8 K (-19.57 %) |
| Sep 03 2010 | CBPO | China Biologic Pro ... | Li Lin Ling | Director | Option Exercise | A | 4.00 | 50,000 | 200,000 | 50,000 | |
| Sep 03 2010 | CBPO | China Biologic Pro ... | Li Lin Ling | Director | Sell | S | 13.00 | 770,000 | 10,010,000 | 6,142,624 | 6.9 M to 6.1 M (-11.14 %) |
| Jul 13 2010 | CBPO | China Biologic Pro ... | Cui Xiangmin | Director | Option Exercise | A | 12.26 | 40,000 | 490,400 | 60,000 | |
| Jul 13 2010 | CBPO | China Biologic Pro ... | Shao Sean | Director | Option Exercise | A | 12.26 | 40,000 | 490,400 | 60,000 | |
| Jul 13 2010 | CBPO | China Biologic Pro ... | CHAN LING SIU | Director | Option Exercise | A | 12.26 | 40,000 | 490,400 | 190,000 | |
| Jul 13 2010 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | Chief Financial Off ... | Option Exercise | A | 12.26 | 35,000 | 429,100 | 160,000 | |
| Jul 13 2010 | CBPO | China Biologic Pro ... | Zhao Chao Ming | Chief Executive Off ... | Option Exercise | A | 12.26 | 40,000 | 490,400 | 155,000 | |
| Jul 13 2010 | CBPO | China Biologic Pro ... | Lin Tong Jun | Director | Option Exercise | A | 12.26 | 40,000 | 490,400 | 60,000 | |
| Jun 29 2010 | CBPO | China Biologic Pro ... | Zhao Chao Ming | Chief Executive Off ... | Sell | J | 0.00 | 1,021,787 | 0 | 1,021,787 | 2 M to 1 M (-50.00 %) |
| Feb 08 2010 | CBPO | China Biologic Pro ... | Kuo Yuyun Tristan | Chief Financial Off ... | Option Exercise | A | 12.60 | 50,000 | 630,000 | 125,000 | |
| Dec 14 2009 | CBPO | China Biologic Pro ... | Zhao Chao Ming | Chief Executive Off ... | Sell | S | 9.13 | 17,096 | 156,069 | 1,021,787 | 1 M to 1 M (-1.65 %) |
| Dec 14 2009 | CBPO | China Biologic Pro ... | Zhao Chao Ming | Chief Executive Off ... | Sell | S | 9.10 | 2,904 | 26,426 | 1,038,883 | 1 M to 1 M (-0.28 %) |
| Dec 14 2009 | CBPO | China Biologic Pro ... | Zhao Chao Ming | Chief Executive Off ... | Sell | S | 9.00 | 30,000 | 270,000 | 1,041,787 | 1.1 M to 1 M (-2.80 %) |
| Jun 09 2009 | CBPO | China Biologic Pro ... | KITT BARRY M | 10% Owner | Sell | S | 4.10 | 175,224 | 718,418 | 311,576 | 486.8 K to 311.6 K (-36.00 %) |
| Jun 09 2009 | CBPO | China Biologic Pro ... | KITT BARRY M | 10% Owner | Sell | S | 4.10 | 718,776 | 2,946,982 | 1,281,224 | 2 M to 1.3 M (-35.94 %) |
| May 20 2009 | CBPO | China Biologic Pro ... | KITT BARRY M | 10% Owner | Sell | S | 4.10 | 100,000 | 410,000 | 486,800 | 586.8 K to 486.8 K (-17.04 %) |
| May 01 2009 | CBPO | China Biologic Pro ... | KITT BARRY M | 10% Owner | Sell | S | 3.46 | 110,818 | 383,486 | 2,000,000 | 2.1 M to 2 M (-5.25 %) |
| May 16 2008 | CBPO | China Biologic Pro ... | Zhao Chao Ming | Chief Financial Off ... | Option Exercise | A | 4.00 | 115,000 | 460,000 | 1,186,787 | |
| May 16 2008 | CBPO | China Biologic Pro ... | CHAN LING SIU | Director | Option Exercise | A | 4.00 | 50,000 | 200,000 | 6,912,624 | |
| May 16 2008 | CBPO | China Biologic Pro ... | Li Lin Ling | Director | Option Exercise | A | 4.00 | 50,000 | 200,000 | 6,912,624 | |
| May 16 2008 | CBPO | China Biologic Pro ... | WONG CBPO STANLEY | Chief Executive Off ... | Option Exercise | A | 4.00 | 50,000 | 200,000 | 50,000 |